- The trend backdrop is active with a 10-week active streak.
- Price is above the Trend Line, keeping the weekly tape constructive.
- Activity pressure is positive on the latest completed week.
- Activity pressure is constructive, supporting the smart-money activity read.
NEWBRY
STO
Week ended 07 Aug 2026
Weekly Investor Report
Newbury Pharmaceuticals AB (publ) · Healthcare · Drug Manufacturers - Specialty & Generic
Latest close
2.70 SEK
-3.6%
latest week
Weekly setup
Constructive, but selective
The weekly trend is active. Price is 73.8% above the Trend Line and sits at 82.9% of its 52-week range. The latest completed week returned -3.6%, after a 11.6% four-week move. The latest news-sentiment score is 50/100. Near-term considerations: volume confirmation is below normal.
Setup score
59
out of 100
Latest Close
2.70 SEK
7 Aug 2026
1W Return
-3.6%
latest completed week
4W Return
11.6%
short-term follow-through
12W Return
91.5%
quarterly tape
Trend Breadth
19.2%
10 of 52 weeks active
Volume Ratio
0.7x
vs 13-week average
- Price is below Fair Value, so the market is still discounting the latest tape.
- Recent volatility is running well above the one-year baseline.
- Trend Line remains the key weekly regime level.
- Activity pressure is the gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through
-3.6%
Latest completed week; four-week move 11.6%.
Indicator stack
45/72
Trend and activity pressure are weighted against the latest 12-week confirmation window.
Trend backdrop
Active
The trend backdrop defines the current weekly regime.
Patient Capital
Quiet
Activity-pressure buy-signal status for institutional accumulation timing.
News sentiment
50/100
3 relevant articles in the latest sentiment read.
01 · Price action
Study the full chart
Where price is—and whether the trend supports it
The weekly trend is active. Price is 73.8% above the Trend Line and sits at 82.9% of its 52-week range. The latest completed week returned -3.6%, after a 11.6% four-week move.
52-week price path
Price vs Trend Line and Fair Value
Price
Trend Line
Fair Value
02 · Volume and demand
Is real participation confirming the move?
Latest weekly volume is 0.7x the 13-week average. Participation is below its recent norm, so price strength is not receiving full volume confirmation.
26-week volume confirmation
Bar height shows volume; colour shows the weekly price direction
13 Feb
20 Feb
27 Feb
6 Mar
13 Mar
20 Mar
27 Mar
3 Apr
10 Apr
17 Apr
24 Apr
1 May
8 May
15 May
22 May
29 May
5 Jun
12 Jun
19 Jun
26 Jun
3 Jul
10 Jul
17 Jul
24 Jul
31 Jul
7 Aug
Up week
Down week
Demand beneath price
Activity pressure and institutional-style signals
These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.
Activity pressure path
Latest 0.8912-week average 0.55
12-week confirmation
Trend active10/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure12/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership6/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.89Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers
No recent accumulation markers. No reversal markers.
03 · Momentum and leadership
Is performance persistent—and is the stock leading?
Performance is 11.6% over four weeks, 91.5% over 12 weeks, and 0.7% over one year. The current trend has remained active for 10 consecutive weeks.
Performance by holding period
Active trend streak10 weeks
Active weeks in one year10
Trend breadth19.2%
Activity pressure vs relative leadership
Activity pressureRelative leadership
Pressure1.27Latest activity-pressure read.
Pressure change-14.3%Four-week change in activity pressure.
Leadership36.10Latest relative-leadership reading.
RS change52.5%Four-week change in relative leadership.
04 · Fundamentals and valuation
Open full factor analysis
What investors are paying for—and the quality behind it
A published fundamentals and factor snapshot is not available for this company.
No published fundamental snapshot is available for this company.
05 · Ownership, options, and sentiment
What other market participants are doing
Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.
Insider activity-
No recent insider transactions are stored for this company.
News sentiment50/100
Weighted news tone is neutral across 3 relevant articles.
0 positive · 3 neutral · 0 negativePatient CapitalQuiet
Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal
06 · Catalysts and risk
What can move the shares—and how volatile the path has been
Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.
Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-12.9%Distance below the 52-week high.
13-week volatility12.9%Standard deviation of weekly returns.
Weekly gains and losses
Latest 26 completed weeksEach bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.
13 Feb
13 Mar
10 Apr
8 May
5 Jun
3 Jul
7 Aug
Weeks higher17 of 268 weeks finished lower.
Best week+43.0%Week of 5 Jun.
Worst week-9.9%Week of 20 Mar.
Latest week-3.6%Week of 7 Aug.
Shape of recent returns
Strong gains9
Modest gains8
Flat weeks1
Modest losses4
Sharp losses4
Recent vol12.9%13-week weekly-return volatility.
Base vol9.4%52-week weekly-return volatility.
Up/down split29/22Count of positive and negative weeks in the 52-week window.
Average skew5.8% / -6.7%Average positive week versus average negative week.
07 · Sector and peer context
Is this stock leading—or simply moving with its group?
Sector and industry breadth distinguish company-specific strength from a broad group move.
SectorSE Healthcare
4-week rank- / 100
Group average-1.1%
Trend breadth39.0%
Trend39.0%active weekly trend signals
MD42.0%positive activity pressure
RS21.0%positive relative leadership
Four-week leaders
IndustrySE Drug Manufacturers - Specialty & Generic
4-week rank5 / 19
Group average1.8%
Trend breadth15.8%
Trend15.8%active weekly trend signals
MD36.8%positive activity pressure
RS21.1%positive relative leadership
Four-week leaders
08 · Evidence and weekly data
The underlying research record
Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.
Weekly tape54/100
Trend, activity pressure, participation, and risk combine to a 54/100 tape read.
Indicator analysis76/100Latest 12-week confirmation: trend 10/12, activity pressure 12/12, relative leadership 6/12.
Activity pressure 0.89; No reversal markers Factors50/100No published factor snapshot is available yet.
Patient CapitalQuietActivity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal Sentiment50/100Weighted news tone is neutral across 3 relevant articles.
APIMEDS PHARMACEUTICALS US (APUS) Stock Price, News & Analysis Insiders50/100No recent insider transaction evidence is stored.
Earnings50/100No stored earnings event is currently attached to this ticker.
| Week | Close | Return | Trend Line | Fair Value | Pressure | Leadership | Volume | Trend |
|---|---|---|---|---|---|---|---|---|
| 7 Aug 2026 | 2.70 SEK | -3.6% | 1.55 SEK | 2.89 SEK | 1.27 | 36.10 | 173.5K | On |
| 31 Jul 2026 | 2.80 SEK | 7.7% | 1.50 SEK | 2.90 SEK | 1.44 | 43.00 | 195.7K | On |
| 24 Jul 2026 | 2.60 SEK | 4.0% | 1.45 SEK | 2.90 SEK | 1.46 | 34.05 | 144.2K | On |
| 17 Jul 2026 | 2.50 SEK | 3.3% | 1.41 SEK | 2.91 SEK | 1.47 | 30.29 | 239.1K | On |
| 10 Jul 2026 | 2.42 SEK | 18.6% | 1.36 SEK | 2.92 SEK | 1.48 | 23.67 | 1.2M | On |
| 3 Jul 2026 | 2.04 SEK | 14.3% | 1.33 SEK | 2.92 SEK | 1.37 | 1.06 | 63.5K | On |
| 26 Jun 2026 | 1.78 SEK | -7.0% | 1.31 SEK | 2.93 SEK | 1.35 | -10.34 | 24.7K | On |
| 19 Jun 2026 | 1.92 SEK | 3.2% | 1.30 SEK | 2.94 SEK | 1.38 | -5.86 | 211.6K | On |
| 12 Jun 2026 | 1.86 SEK | -8.4% | 1.29 SEK | 2.96 SEK | 1.38 | -8.37 | 145.7K | On |
| 5 Jun 2026 | 2.03 SEK | 43.0% | 1.27 SEK | 2.97 SEK | 1.37 | -1.43 | 105.4K | On |
| 29 May 2026 | 1.42 SEK | 1.1% | 1.27 SEK | 2.98 SEK | 1.39 | -32.31 | 272.6K | Off |
| 22 May 2026 | 1.41 SEK | -0.4% | 1.30 SEK | 2.99 SEK | 1.32 | -34.34 | 206.5K | Off |
| 15 May 2026 | 1.41 SEK | 2.5% | 1.34 SEK | 3.01 SEK | 1.27 | -32.92 | 160.0K | Off |
| 8 May 2026 | 1.38 SEK | 0.4% | 1.37 SEK | 3.04 SEK | 1.32 | -36.36 | 321.0K | Off |
How to use this report
This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.